Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2012 16:30 ET | Source: Bio Green Med Solution, Inc.

Cyclacel to Announce Year-End and Fourth Quarter 2011 Financial Results and Multiple Presentations at the Upcoming AACR Conference

BERKELEY HEIGHTS, N.J., March 26, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today announced upcoming corporate events. Year...
March 22, 2012 16:30 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Announces $3.0 Million Financing to Fund Ongoing Litigation Expenses on Certain Intellectual Property

BERKELEY HEIGHTS, N.J., March 22, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), today announced that the Company entered into a...
February 13, 2012 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Provides Update on Clinical Progress With Sapacitabine as Second Line Therapy in Older Patients With Myelodysplastic Syndromes

BERKELEY HEIGHTS, N.J., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), announced today new topline response data from an...
February 06, 2012 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel to Present at Upcoming Investor Conferences

BERKELEY HEIGHTS, N.J., Feb. 6, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today that Spiro Rombotis, President and...
January 11, 2012 12:15 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Provides Corporate Update at OneMedForum Conference

BERKELEY HEIGHTS, N.J., Jan. 11, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today summarized its 2011 achievements and set forth...
January 06, 2012 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel to Present at the 5th Annual OneMedForum in San Francisco

BERKELEY HEIGHTS, N.J., Jan. 6, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today announced that Spiro Rombotis, President and...
December 12, 2011 13:00 ET | Source: Bio Green Med Solution, Inc.

Updated Results From Cyclacel Clinical Study Highlight Safety and Efficacy of Sequential Administration of Sapacitabine and Decitabine in Elderly Patients With AML

BERKELEY HEIGHTS, N.J., Dec. 12, 2011 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP); (Cyclacel or the Company), announced today updated results from an ongoing,...
December 07, 2011 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Provides Update on Clinical Progress With Sapacitabine in Solid Tumors Including Activity in BRCA Mutation-Positive Patients

- Partial responses and stable disease observed in patients with lung cancer and also in patients with breast, pancreatic and ovarian cancer carrying BRCA mutations - - Sapacitabine unique among...
December 01, 2011 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel to Webcast Analyst & Institutional Investor Meeting Wednesday, December 7, 2011

BERKELEY HEIGHTS, N.J., Dec. 1, 2011 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), will host an Analyst and Institutional Investor meeting...
November 14, 2011 16:01 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Reports Third Quarter 2011 Financial Results

SEAMLESS Phase 3 trial design simplified; FDA confirmed that SPA remains valid Conference Call Scheduled November 14, 2011 at 4:30 p.m. Eastern Time BERKELEY HEIGHTS, N.J., Nov. 14, 2011...